# Zura Bio (ZURA): Phase 2 Data, a 69.7% Drop

> Source: IndicatorStack, https://indicatorstack.com/catalysts/zura-2026-11-09-data. Updated Nov 19, 2026, 4:45 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

Zura Bio (ZURA) released clinical update on Phase 2 TibuSHIELD study of tibulizumab (ZB-106) at 7:00 AM ET on Monday, November 9, and the stock went from Friday’s $4.09 close to as low as $0.9342. It finished the session −69.7% at $1.24 on 12.5 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 4:00 AM ET. NASDAQ: ZURA, Biotechnology. All times ET.

## The numbers

- −69.7% Monday’s close ($4.09 to $1.24, low $0.9342)
- 12.5× its 20-day average volume (64.3M shares on the day)
- 7:00 AM the catalyst crossed, ET (Monday, before the open)
- 45.6M float, shares (1.4× the float traded on Monday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Fri close | $4.08 | Bullish, firm | Higher timeframes up |
| Into the open | Mon 9:30 AM | $1.27 | Bearish, weakening | Tailwind down |
| 30 minutes in | Mon 10:00 AM | $1.07 | Bearish, strong | Tailwind down |
| At the close | Mon 4:00 PM | $1.24 | Bullish, strong | Higher timeframes still down |
| Tuesday’s close | Tue 4:00 PM | $1.41 | Neutral | Tailwind down |
| Wednesday’s close | Wed 4:00 PM | $1.42 | Bearish, strong | Tailwind down |
| Thursday’s close | Thu 4:00 PM | $1.24 | Bearish, weakening | Tailwind down |

## Timeline

### Monday, November 9

- 4:00 AM: Premarket high $4.27 (+4.4% from the prior close)
- 7:00 AM: Clinical update on Phase 2 TibuSHIELD study of tibulizumab (ZB-106) (Press release, Business Wire)
- 7:07 AM: Current report (Form 8-K) filed (Accepted by the SEC at 7:07:11 AM ET)
- 7:10 AM: 5-minute stack bias turned bearish (at $1.27)
- 9:30 AM: Opened at $1.27 (−68.9% from Friday’s $4.09 close)
- 10:15 AM: Tripwire flagged a trap at the lows (a push through support that failed to hold, at $0.9649)
- 10:35 AM: Session low $0.9342
- 12:15 PM: 5-minute stack bias went neutral (at $1.13, its inputs no longer agreeing)
- 12:25 PM: Tripwire flagged a trap at the highs (a push through resistance that failed to hold, at $1.14)
- 12:40 PM: 5-minute stack bias turned bullish (at $1.14)
- 4:00 PM: Closed at $1.24, −69.7% on the day (64.3M shares, 12.5× its 20-day average)

### Tuesday, November 10

- 7:10 AM: 5-minute stack bias turned bearish (at $1.20)
- 8:33 AM: Investors Have Opportunity to Join Zura Bio Limited Fraud Investigation (Press release, Business Wire)
- 9:30 AM: Session low $1.16
- 9:30 AM: Opened at $1.17 (−5.6% from Monday’s $1.24 close)
- 9:40 AM: 5-minute stack bias went neutral (at $1.33, its inputs no longer agreeing)
- 9:45 AM: 5-minute stack bias turned bullish (at $1.42)
- 10:09 AM: SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of (Press release, PRNewsWire)
- 10:20 AM: Session high $1.53
- 3:00 PM: 5-minute stack bias went neutral (at $1.37, its inputs no longer agreeing)
- 3:10 PM: 5-minute stack bias turned bearish (at $1.37)
- 3:55 PM: 5-minute stack bias went neutral (at $1.41, its inputs no longer agreeing)
- 4:00 PM: Closed at $1.41, +13.7% on the day (17M shares, 2.1× its 20-day average)

### Wednesday, November 11

- 9:30 AM: Opened at $1.41 (+0.0% from Tuesday’s $1.41 close)
- 9:45 AM: 5-minute stack bias went neutral (at $1.39, its inputs no longer agreeing)
- 9:55 AM: 5-minute stack bias turned bearish (at $1.39)
- 10:05 AM: Session low $1.35
- 10:25 AM: 5-minute stack bias went neutral (at $1.42, its inputs no longer agreeing)
- 10:45 AM: 5-minute stack bias turned bullish (at $1.45)
- 11:20 AM: Session high $1.58
- 2:25 PM: 5-minute stack bias went neutral (at $1.49, its inputs no longer agreeing)
- 2:55 PM: 5-minute stack bias turned bearish (at $1.45)
- 4:00 PM: Closed at $1.43, +1.4% on the day (6.9M shares, 0.9× its 20-day average)

### Thursday, November 12

- 7:25 AM: 5-minute stack bias turned bearish (at $1.41)
- 9:30 AM: Opened at $1.41 (−1.4% from Wednesday’s $1.43 close)
- 2:35 PM: Session low $1.21
- 4:00 PM: Closed at $1.24, −13.3% on the day (3.5M shares, 0.4× its 20-day average)

## Before the catalyst (Friday, November 6)

Zura Bio closed Friday at $4.09. The 5-minute stack bias was bullish (firm), since 11:20 AM: held from earlier bars; none of its inputs pull its way on this bar. Compass read “Higher timeframes up” (15m ↗ 1h ↗ 2h ↗ 4h ↗ D ↘). Undertow: volume surge, sellers hitting the bid. Tripwire: Longs: Avoid, support looks fake, heavy tape on it. Its Next row read “Lost VWAP 4.08, buyers need a reclaim”.

Over the year before, it had traded between $3.25 and $7.44.

## The Phase 2 data and a 69.7% drop (Monday, November 9)

The release crossed at 7:00 AM ET, with the company’s Form 8-K accepted by the SEC at 7:07 AM. Premarket trading carried it to $4.27 by 4:00 AM, +4% from the prior close, on 559K shares before the bell. It opened at $1.27, −68.9%, and the regular session ranged from $0.9342 to $1.27 before closing at $1.24. It did this on a day SPY rose 2.4% and XBI, the biotechnology ETF, rose 3.1%.

Into the open the stack read it as bearish (weakening) with 5 of 5 higher timeframes down, and Undertow read “volume surge”. Thirty minutes in, the picture had changed: price was below VWAP at $1.16 and the Next row read “Stretched below the averages, bounce area near 1.13”. By the close the 5-minute bias was bullish from 12:40 PM, while Compass still read “Higher timeframes still down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Tuesday, November 10)

It opened at $1.17 (−5.6%) and traded from $1.16 to $1.53, closing at $1.41, +13.7% on 17M shares, still 2.1 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “Tailwind down” (15m ↑ 1h ↘ 2h ↘ 4h ↓ D ↘). Undertow: volume surge, buyers hitting the offer. Tripwire: Longs: Clean, nothing major in the way.

## The session after (Wednesday, November 11)

It opened at $1.41 (+0.0%) and traded from $1.35 to $1.58, closing at $1.43, +1.4% on 6.9M shares, still 0.9 times its 20-day average. The 5-minute stack bias was bearish (strong), since 2:55 PM: under VWAP 1.46 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “Tailwind down” (15m ↓ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.

## The session after (Thursday, November 12)

It opened at $1.41 (−1.4%) and traded from $1.21 to $1.44, closing at $1.24, −13.3% on 3.5M shares, still 0.4 times its 20-day average. The 5-minute stack bias was bearish (weakening), since 7:25 AM: under VWAP 1.26 and trend strength with the sellers. Compass read “Tailwind down” (15m ↓ 1h ↘ 2h ↘ 4h ↓ D ↓). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Avoid, resistance looks thin, buying tape on it.

After hours it last traded at $1.23, with Undertow reading “buyers pushing back”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 96.3M | as reported to the SEC |
| Float | 45.6M | 47% of shares outstanding |
| Last insider purchase | February 26, 2026 | 2M shares at $6.25 by AI Biotechnology LLC (10 percent owner) |
| Last insider sale | November 25, 2024 | 1M shares at $2.73 |

## Sources

- Tue Nov 10, 10:09 AM ET, Press release: SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of (PRNewsWire) https://www.prnewswire.com/news-releases/zura-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-zura-bio-limited-302934820.html
- Tue Nov 10, 8:33 AM ET, Press release: Investors Have Opportunity to Join Zura Bio Limited Fraud Investigation (Business Wire) https://www.businesswire.com/news/home/20261110843740/en/ZURA-Investors-Have-Opportunity-to-Join-Zura-Bio-Limited-Fraud-Investigation-with-SBS-Law/
- Mon Nov 9, 7:07 AM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1855644/000110465926124149/tm2629310d1_8k.htm
- Mon Nov 9, 7:00 AM ET, Press release: Clinical update on Phase 2 TibuSHIELD study of tibulizumab (ZB-106) (Business Wire) https://www.businesswire.com/news/home/20261109871255/en/Zura-Bio-Provides-Clinical-Update-on-Phase-2-TibuSHIELD-Study-of-Tibulizumab-ZB-106-in-Hidradenitis-Suppurativa/

## Questions

### Why did ZURA stock go down on November 9?

Zura Bio (ZURA) released clinical update on Phase 2 TibuSHIELD study of tibulizumab (ZB-106) at 7:00 AM ET on Monday, November 9, and the stock went from Friday’s $4.09 close to as low as $0.9342. It finished the session −69.7% at $1.24 on 12.5 times its 20-day average volume. The reaction describes the sequence and infers no cause.

### What did Zura Bio announce on November 9, 2026?

Zura Bio (ZURA) released clinical update on Phase 2 TibuSHIELD study of tibulizumab (ZB-106) at 7:00 AM ET on Monday, November 9. The company’s release and its Form 8-K are linked in the sources on this page.

### How did ZURA stock trade on November 9?

ZURA opened at $1.27, −68.9% from the prior close of $4.09, traded between $0.9342 and $1.27 in the regular session and closed at $1.24, −69.7%, on 64.3M shares.

### How did LiveChart’s stack read ZURA at the close on November 9?

At the 4:00 PM ET close the 5-minute stack bias on ZURA was bullish (strong), Compass read “Higher timeframes still down” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on ZURA now?

The read on this page is fixed at each moment it describes. LiveChart reads ZURA on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/ZURA. ZURA catalyst history: https://indicatorstack.com/catalysts/stock/ZURA

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
